Canopy Growth (CGC) Retained Earnings (2017 - 2026)
Canopy Growth (CGC) reported Retained Earnings of -$8.1 billion for Q1 2026, down 2178469.77% on a YoY basis from N/an in Q1 2025, and down 3.12% sequentially from -$7.9 billion in Q4 2025.
Canopy Growth (CGC) Retained Earnings (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Retained Earnings data on file, last reported at -$8.1 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 2178469.77% year-over-year to -$8.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$8.1 billion (down 2178469.77% YoY), and the FY2026 full-year result was -$8.1 billion, down 2178469.77% from the prior year.
- Retained Earnings slipped to -$8.1 billion in Q1 2026, from -$7.9 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $575527.6 in Q1 2022 to a low of -$8.1 billion in Q1 2026.
- A 5-year average of -$6.6 billion and a median of -$7.5 billion in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings soared 100.01% in 2022 and tumbled 2178469.77% in 2026, its largest moves.
- Tracing CGC's Retained Earnings over 5 years: stood at -$6.7 billion in 2022, then declined by 12.79% to -$7.5 billion in 2023, then fell by 1.86% to -$7.6 billion in 2024, then fell by 3.03% to -$7.9 billion in 2025, then decreased by 3.12% to -$8.1 billion in 2026.
- Business Quant data shows CGC's Retained Earnings at -$8.1 billion in Q1 2026, -$7.9 billion in Q4 2025, and -$7.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | -8.12 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.12 Bn |
| Dec 31, 2025 | -7.88 Bn |
| Sep 30, 2025 | -7.94 Bn |
| Jun 30, 2025 | -7.88 Bn |
| Mar 31, 2025 | 372,850.31 |
| Dec 31, 2024 | -7.64 Bn |
| Sep 30, 2024 | -7.76 Bn |
| Jun 30, 2024 | -7.66 Bn |
| Mar 31, 2024 | -7.69 Bn |
| Dec 31, 2023 | -7.51 Bn |
| Sep 30, 2023 | -7.47 Bn |
| Jun 30, 2023 | -7.23 Bn |
| Mar 31, 2023 | -7.15 Bn |
| Dec 31, 2022 | -6.65 Bn |
| Sep 30, 2022 | -6.73 Bn |
| Jun 30, 2022 | -6.64 Bn |
| Mar 31, 2022 | 575,527.57 |
| Dec 31, 2021 | -4.60 Bn |
| Sep 30, 2021 | -4.52 Bn |
| Jun 30, 2021 | -4.62 Bn |